BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fritsch M, Koliaki C, Livingstone R, Phielix E, Bierwagen A, Meisinger M, Jelenik T, Strassburger K, Zimmermann S, Brockmann K, Wolff C, Hwang JH, Szendroedi J, Roden M. Time course of postprandial hepatic phosphorus metabolites in lean, obese, and type 2 diabetes patients. Am J Clin Nutr 2015;102:1051-8. [PMID: 26423389 DOI: 10.3945/ajcn.115.107599] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Legaki AI, Moustakas II, Sikorska M, Papadopoulos G, Velliou RI, Chatzigeorgiou A. Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease. Curr Obes Rep 2022. [PMID: 35501558 DOI: 10.1007/s13679-022-00473-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Guerra S, Mocciaro G, Gastaldelli A. "Adipose tissue insulin resistance and lipidome alterations are the characterizing factors of NASH". Eur J Clin Invest 2021;:e13695. [PMID: 34695228 DOI: 10.1111/eci.13695] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
3 Hoene M, Kappler L, Kollipara L, Hu C, Irmler M, Bleher D, Hoffmann C, Beckers J, Hrabě de Angelis M, Häring HU, Birkenfeld AL, Peter A, Sickmann A, Xu G, Lehmann R, Weigert C. Exercise prevents fatty liver by modifying the compensatory response of mitochondrial metabolism to excess substrate availability. Mol Metab 2021;:101359. [PMID: 34695608 DOI: 10.1016/j.molmet.2021.101359] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Tsilingiris D, Tzeravini E, Koliaki C, Dalamaga M, Kokkinos A. The Role of Mitochondrial Adaptation and Metabolic Flexibility in the Pathophysiology of Obesity and Insulin Resistance: an Updated Overview. Curr Obes Rep 2021;10:191-213. [PMID: 33840072 DOI: 10.1007/s13679-021-00434-0] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
5 Pafili K, Roden M. Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans. Mol Metab 2021;50:101122. [PMID: 33220492 DOI: 10.1016/j.molmet.2020.101122] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
6 Rothe M, Wessel C, Cames S, Szendroedi J, Burkart V, Hwang JH, Roden M. In vivo absolute quantification of hepatic γ-ATP concentration in mice using 31 P MRS at 11.7 T. NMR Biomed 2021;34:e4422. [PMID: 33025629 DOI: 10.1002/nbm.4422] [Reference Citation Analysis]
7 Böhm A, Keuper M, Meile T, Zdichavsky M, Fritsche A, Häring HU, de Angelis MH, Staiger H, Franko A. Increased mitochondrial respiration of adipocytes from metabolically unhealthy obese compared to healthy obese individuals. Sci Rep 2020;10:12407. [PMID: 32709986 DOI: 10.1038/s41598-020-69016-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
8 Li K, Zhao B, Wei D, Wang W, Cui Y, Qian L, Liu G. miR‑146a improves hepatic lipid and glucose metabolism by targeting MED1. Int J Mol Med 2020;45:543-55. [PMID: 31894315 DOI: 10.3892/ijmm.2019.4443] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
9 Léveillé M, Estall JL. Mitochondrial Dysfunction in the Transition from NASH to HCC. Metabolites 2019;9:E233. [PMID: 31623280 DOI: 10.3390/metabo9100233] [Cited by in Crossref: 18] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
10 Gancheva S, Ouni M, Jelenik T, Koliaki C, Szendroedi J, Toledo FGS, Markgraf DF, Pesta DH, Mastrototaro L, De Filippo E, Herder C, Jähnert M, Weiss J, Strassburger K, Schlensak M, Schürmann A, Roden M. Dynamic changes of muscle insulin sensitivity after metabolic surgery. Nat Commun 2019;10:4179. [PMID: 31519890 DOI: 10.1038/s41467-019-12081-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
11 Scheiber D, Jelenik T, Zweck E, Horn P, Schultheiss HP, Lassner D, Boeken U, Saeed D, Kelm M, Roden M, Westenfeld R, Szendroedi J. High-resolution respirometry in human endomyocardial biopsies shows reduced ventricular oxidative capacity related to heart failure. Exp Mol Med 2019;51:1-10. [PMID: 30765687 DOI: 10.1038/s12276-019-0214-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
12 Ruegsegger GN, Creo AL, Cortes TM, Dasari S, Nair KS. Altered mitochondrial function in insulin-deficient and insulin-resistant states. J Clin Invest 2018;128:3671-81. [PMID: 30168804 DOI: 10.1172/JCI120843] [Cited by in Crossref: 52] [Cited by in F6Publishing: 66] [Article Influence: 13.0] [Reference Citation Analysis]
13 Weber KS, Straßburger K, Fritsch M, Bierwagen A, Koliaki C, Phielix E, Pacini G, Hwang JH, Markgraf DF, Burkart V, Müssig K, Szendroedi J, Roden M. Meal-derived glucagon responses are related to lower hepatic phosphate concentrations in obesity and type 2 diabetes. Diabetes Metab 2018;44:444-8. [PMID: 29910091 DOI: 10.1016/j.diabet.2018.05.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
14 Kahl S, Nowotny B, Strassburger K, Bierwagen A, Klüppelholz B, Hoffmann B, Giani G, Nowotny PJ, Wallscheid F, Hatziagelaki E, Pacini G, Hwang J, Roden M. Amino Acid and Fatty Acid Levels Affect Hepatic Phosphorus Metabolite Content in Metabolically Healthy Humans. The Journal of Clinical Endocrinology & Metabolism 2018;103:460-8. [DOI: 10.1210/jc.2017-01773] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
15 Jelenik T, Kaul K, Séquaris G, Flögel U, Phielix E, Kotzka J, Knebel B, Fahlbusch P, Hörbelt T, Lehr S, Reinbeck AL, Müller-Wieland D, Esposito I, Shulman GI, Szendroedi J, Roden M. Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver. Diabetes 2017;66:2241-53. [PMID: 28490610 DOI: 10.2337/db16-1147] [Cited by in Crossref: 72] [Cited by in F6Publishing: 83] [Article Influence: 14.4] [Reference Citation Analysis]
16 Hernández EÁ, Kahl S, Seelig A, Begovatz P, Irmler M, Kupriyanova Y, Nowotny B, Nowotny P, Herder C, Barosa C, Carvalho F, Rozman J, Neschen S, Jones JG, Beckers J, de Angelis MH, Roden M. Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance. J Clin Invest 2017;127:695-708. [PMID: 28112681 DOI: 10.1172/JCI89444] [Cited by in Crossref: 76] [Cited by in F6Publishing: 91] [Article Influence: 15.2] [Reference Citation Analysis]
17 Sunny NE, Bril F, Cusi K. Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies. Trends Endocrinol Metab. 2017;28:250-260. [PMID: 27986466 DOI: 10.1016/j.tem.2016.11.006] [Cited by in Crossref: 118] [Cited by in F6Publishing: 152] [Article Influence: 19.7] [Reference Citation Analysis]
18 Tilg H, Moschen AR, Roden M. NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol. 2017;14:32-42. [PMID: 27729660 DOI: 10.1038/nrgastro.2016.147] [Cited by in Crossref: 445] [Cited by in F6Publishing: 414] [Article Influence: 74.2] [Reference Citation Analysis]
19 Morris EM, Meers GM, Koch LG, Britton SL, Fletcher JA, Fu X, Shankar K, Burgess SC, Ibdah JA, Rector RS, Thyfault JP. Aerobic capacity and hepatic mitochondrial lipid oxidation alters susceptibility for chronic high-fat diet-induced hepatic steatosis. Am J Physiol Endocrinol Metab 2016;311:E749-60. [PMID: 27600823 DOI: 10.1152/ajpendo.00178.2016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]